STI
24
-7
DAL
64
2
UAL
76
3
MTCH
40
-10
ALL
37
-3
T
45
-2
DTE
47
-2
ROST
66
-2
EMC
77
6
NTRS
35
-14
SJM
21
-3
APH
64
3
FOX
53
-2
CAH
41
-6
ESS
59
2
VMC
51
3
URBN
70
-2
MOS
50
4
TAP
61
-3
NKE
42
6
STI
24
-7
DAL
64
2
UAL
76
3
MTCH
40
-10
ALL
37
-3
T
45
-2
DTE
47
-2
ROST
66
-2
EMC
77
6
NTRS
35
-14
SJM
21
-3
APH
64
3
FOX
53
-2
CAH
41
-6
ESS
59
2
VMC
51
3
URBN
70
-2
MOS
50
4
TAP
61
-3
NKE
42
6
Financhill
Back

Revolution Medicines 10K Form

Sell
49

RVMD
Revolution Medicines

Last Price:
46.45
Seasonality Move:
-1.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RVMD News And Ratings

See the #1 stock for the next 7 days that we like better than RVMD

RVMD Financial Statistics

Sales & Book Value

Annual Sales: $11.58M
Cash Flow: $-133.94M
Price / Cash Flow: 0
Annual Sales: $9.34
Price / Book: 5.08

Profitability

EPS (TTM): -3.66000
Net Income (TTM): $-567.06M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Revolution Medicines Earnings Forecast

Key Revolution Medicines Financial Ratios

  • The Research & Development expenses have been 3,654.09% of Revenue.
  • The Interest Expense is -0.07% of Operating Income.
  • The Net Earning history of RVMD is -3,768.28% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Revolution Medicines Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RVMD
CUSIP: 76155X
Website: revmed.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RVMD Technical Analysis vs Fundamental Analysis

Sell
49
Revolution Medicines (RVMD) is a Sell

Is Revolution Medicines a Buy or a Sell?